<DOC>
	<DOCNO>NCT01858857</DOCNO>
	<brief_summary>The purpose observational multicenter-study investigate safety psychopharmacological treatment rate adverse drug reaction gerontopsychiatric inpatient . Elderly people high risk develop side effect pharmacological treatment due alter metabolic situation , high comorbidity rate often polypharmacy . Furthermore gerontopsychiatric patient often articulate symptom clearly , example due pronounce cognitive impairment . The aim study gain valid data possible adverse drug reaction rate , potential risk factor outcome , well medical prescription practises . To assess outcomes intensive pharmacovigilance-monitoring conduct five participate study site . At Baseline demographic data , previous present disorder , use drug , previous present medication , quality life , cognitive function , physical examination result , laboratory result ECG assess . Afterwards patient visit weekly screen possible adverse drug reaction . All adverse drug reaction cod MedDRA-system . In case possible serious adverse drug reaction serum level psychotropic substance applicated assessed . Drug combination analyse use establish advanced bioinformatic tool ( mediQ ) . Diagnosis , medication intake possible adverse drug reaction document continually . 2 week discharge ward , patient contact phone ass catamnestic data .</brief_summary>
	<brief_title>Geriatric Psychiatry Pharmacovigilance</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Psychophysiologic Disorders</mesh_term>
	<criteria>1 . Age 65+ year old 2 . Inpatients treat one geriatric psychiatry study site . 3 . Signed consent form ( Patient and/or legally authorized custodian ) 1 . Patients incapable give inform consent legally authorize custodianship .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>geriatric psychiatry</keyword>
	<keyword>pharmacovigilance</keyword>
</DOC>